Actavis Recalls Diclofenac Sodium and Misoprostol Tablets Due to Splitting
Actavis is recalling 36,538 bottles of Diclofenac Sodium and Misoprostol tablets due to complaints of split or broken tablets.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves physical defects (split/broken tablets) without reported injuries or illnesses, fitting the criteria for a moderate severity recall.
Plain-English summary
Actavis Laboratories, FL, Inc. is recalling 36,538 bottles of Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count. The recall is being conducted due to complaints of split or broken tablets.
The affected product is a prescription-only medication manufactured by Watson Laboratories, Inc. The specific lots involved are 605956A, 605958A, 644678M, and 661841A, with expiration dates ranging from September 2014 to February 2015. The product was distributed nationwide and in Puerto Rico.
Consumers and healthcare providers should stop using the affected product and return it to the pharmacy or point of purchase. Patients should consult their healthcare provider for alternative treatment options if necessary.
The recalled product
- Product
- DICLOFENAC SODIUM AND MISOPROSTOL (DICLOFENAC SODIUM AND MISOPROSTOL)
- Brand
- DICLOFENAC SODIUM AND MISOPROSTOL
- Manufacturer
- Actavis Laboratories, FL, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 36,538
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot #: 605956A
- 605958A
- Exp. 9/30/2014
- 644678M
- Exp. 10/31/2014
- 661841A
- Exp. 11/30/2014
- 717469A
- Exp 2/28/2015
UPCs (1)
- 305910398606
Distribution
Part of a larger recall action
This product is one of 2 recalled by Actavis Laboratories, FL, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · DICLOFENAC SODIUM AND MISOPROSTOL
- ModerateActavis Recalls Diclofenac Sodium and Misoprostol Tablets Due to Split Tablets
FDA (Drugs) · 2014-12-03
- ModerateActavis Recalls Diclofenac Sodium and Misoprostol Tablets Due to Splitting
FDA (Drugs) · 2014-10-08
- ModerateWatson Recalls Diclofenac Sodium and Misoprostol Tablets Due to Splitting
FDA (Drugs) · 2014-02-19
- ModerateActavis Recalls Diclofenac Sodium and Misoprostol Tablets Due to Broken Tablets
FDA (Drugs) · 2014-02-12
- ModerateWatson Recalls Diclofenac Sodium and Misoprostol Tablets Due to Broken Tablets
FDA (Drugs) · 2013-07-31
Same manufacturer · Actavis Laboratories, FL, Inc.
See all →- LowActavis Recalls Ramipril Capsules Due to Incorrect Expiration Date Labeling
FDA (Drugs) · 2016-11-09
- ModerateActavis Recalls Metformin Hydrochloride Extended-Release Tablets for Dissolution Failure
FDA (Drugs) · 2015-10-21
- LowActavis Recalls Desmopressin Acetate Tablets with Incorrect Imprint
FDA (Drugs) · 2015-08-12
- ModerateActavis Recalls Cartia XT Capsules Due to Aluminum Residue on Exterior
FDA (Drugs) · 2015-04-22
Same hazard · physical defect
See all →- HighThermodilution Catheter May Bend During Use, Causing Monitor Errors
FDA (Devices) · 2023-04-19
- ModerateBard Clean-Cath Intermittent Catheter Recalled for Packaging and Tip Defects
FDA (Devices) · 2021-04-28
- HighFerring Recalls ZOMA-Jet 5 Demonstration Kits Due to Defective Delivery System
FDA (Drugs) · 2021-04-07
- HighROi CPS Recalls Custom Procedure Packs with Flaking Gauze Sponges
FDA (Devices) · 2021-01-06
- HighGE Healthcare Recalls Flow Sensor Service Parts with Damaged Tubes
FDA (Devices) · 2020-11-11